Kristopher Costello, CRNA | |
3001 Avenue A, Dodge City, KS 67801-2270 | |
(620) 225-8400 | |
Not Available |
Full Name | Kristopher Costello |
---|---|
Gender | Male |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 7 Years |
Location | 3001 Avenue A, Dodge City, Kansas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1629586649 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | TMP-155882 (Kansas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Carson Tahoe Regional Medical Center | Carson city, NV | Hospital |
William Bee Ririe Hospital | Ely, NV | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Carson Tahoe Physician Hospital Organization, Llc | 8628465721 | 25 |
News Archive
Penwest Pharmaceuticals Co. today announced that it has signed a drug development and commercialization agreement with Alvogen, Inc. under which Penwest and Alvogen have agreed to identify and select up to five compounds for generic development. Penwest's TIMERx technology may be used for each compound selected.
MedSolutions and Corporate Research Group today announced initial results from a groundbreaking diagnostic accuracy program, which showed shortened hospital stays, reduced emergency room visits and lower overall medical costs among participants.
The brains of people with recurrent depression have a significantly smaller hippocampus - the part of the brain most associated with forming new memories - than healthy individuals, a new global study of nearly 9,000 people reveals.
In what researchers state is the first pilot clinical trial to assess the effects of resveratrol on pain severity and levels of inflammatory biomarkers in patients with mild to moderate knee osteoarthritis, the scientists compared treatment with a nonsteroidal anti-inflammatory drug combined with either resveratrol or placebo over 90 days.
› Verified 5 days ago
Entity Name | William Bee Ririe Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1487648804 PECOS PAC ID: 9335051747 Enrollment ID: O20031104000372 |
News Archive
Penwest Pharmaceuticals Co. today announced that it has signed a drug development and commercialization agreement with Alvogen, Inc. under which Penwest and Alvogen have agreed to identify and select up to five compounds for generic development. Penwest's TIMERx technology may be used for each compound selected.
MedSolutions and Corporate Research Group today announced initial results from a groundbreaking diagnostic accuracy program, which showed shortened hospital stays, reduced emergency room visits and lower overall medical costs among participants.
The brains of people with recurrent depression have a significantly smaller hippocampus - the part of the brain most associated with forming new memories - than healthy individuals, a new global study of nearly 9,000 people reveals.
In what researchers state is the first pilot clinical trial to assess the effects of resveratrol on pain severity and levels of inflammatory biomarkers in patients with mild to moderate knee osteoarthritis, the scientists compared treatment with a nonsteroidal anti-inflammatory drug combined with either resveratrol or placebo over 90 days.
› Verified 5 days ago
Entity Name | Carson Tahoe Physician Hospital Organization, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1063169829 PECOS PAC ID: 8628465721 Enrollment ID: O20220419002777 |
News Archive
Penwest Pharmaceuticals Co. today announced that it has signed a drug development and commercialization agreement with Alvogen, Inc. under which Penwest and Alvogen have agreed to identify and select up to five compounds for generic development. Penwest's TIMERx technology may be used for each compound selected.
MedSolutions and Corporate Research Group today announced initial results from a groundbreaking diagnostic accuracy program, which showed shortened hospital stays, reduced emergency room visits and lower overall medical costs among participants.
The brains of people with recurrent depression have a significantly smaller hippocampus - the part of the brain most associated with forming new memories - than healthy individuals, a new global study of nearly 9,000 people reveals.
In what researchers state is the first pilot clinical trial to assess the effects of resveratrol on pain severity and levels of inflammatory biomarkers in patients with mild to moderate knee osteoarthritis, the scientists compared treatment with a nonsteroidal anti-inflammatory drug combined with either resveratrol or placebo over 90 days.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Kristopher Costello, CRNA 904 Ragan Rd, Dodge City, KS 67801-2950 Ph: (928) 660-2202 | Kristopher Costello, CRNA 3001 Avenue A, Dodge City, KS 67801-2270 Ph: (620) 225-8400 |
News Archive
Penwest Pharmaceuticals Co. today announced that it has signed a drug development and commercialization agreement with Alvogen, Inc. under which Penwest and Alvogen have agreed to identify and select up to five compounds for generic development. Penwest's TIMERx technology may be used for each compound selected.
MedSolutions and Corporate Research Group today announced initial results from a groundbreaking diagnostic accuracy program, which showed shortened hospital stays, reduced emergency room visits and lower overall medical costs among participants.
The brains of people with recurrent depression have a significantly smaller hippocampus - the part of the brain most associated with forming new memories - than healthy individuals, a new global study of nearly 9,000 people reveals.
In what researchers state is the first pilot clinical trial to assess the effects of resveratrol on pain severity and levels of inflammatory biomarkers in patients with mild to moderate knee osteoarthritis, the scientists compared treatment with a nonsteroidal anti-inflammatory drug combined with either resveratrol or placebo over 90 days.
› Verified 5 days ago
Dr. Dana Alan Reynolds, EDD, MS, ARNP-CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2811 Avenue A, Apt. A, Dodge City, KS 67801 Phone: 620-371-6140 | |
Martha Jane Marples, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 100 W Ross Blvd, Dodge City, KS 67801 Phone: 620-225-2847 Fax: 620-225-7046 | |
Jason Witzel, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 107 Corral Way Apt A, Dodge City, KS 67801 Phone: 205-585-1301 | |
Anthony F Bartello, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 100 W Ross Blvd, Dodge City, KS 67801 Phone: 620-225-2847 Fax: 620-225-7046 | |
Mrs. Jacquelyn Edith Rockman, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 500 Cherry St, Dodge City, KS 67801 Phone: 334-549-2903 | |
Terry A Martin, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 W Ross Blvd, Dodge City, KS 67801 Phone: 620-225-2847 Fax: 620-225-7046 |